Related Experiment Video
Updated: Mar 7, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
New developments for the detection and treatment of cardiac vasculopathy
Kevin J Clerkin1, Ziad A Ali, Donna M Mancini
1aDepartment of Medicine, Division of Cardiology, Columbia University Medical Center bCardiovascular Research Foundation cDepartment of Medicine, Division of Cardiology, Icahn School of Medicine at Mount Sinai, New York, USA.
Insights
Cardiac allograft vasculopathy (CAV) diagnosis is improving with new techniques. While treatment options remain limited, earlier detection of CAV offers hope for heart transplant recipients.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Cardiac allograft vasculopathy (CAV) significantly impacts long-term survival post-heart transplantation.
- Effective diagnosis and management of CAV are critical for improving patient outcomes.
Purpose of the Study:
- To review current diagnostic and treatment strategies for CAV.
- To highlight advancements in CAV detection and management.
Main Methods:
- Review of current literature on diagnostic modalities for CAV.
- Analysis of traditional versus innovative diagnostic techniques.
Main Results:
- Advanced diagnostic methods targeting CAV pathophysiology (arterial wall thickening, reduced coronary blood flow) show improved sensitivity over traditional methods like angiography.
- Progress in earlier and more accurate CAV diagnosis has been achieved.
Conclusions:
- Current options for CAV prevention and treatment are limited.
- Further research is essential to optimize immunosuppression timing and explore novel CAV therapies.
Purpose Of Review:
Cardiac allograft vasculopathy (CAV) is a major limitation to long-term survival after heart transplantation. Innovative new techniques to diagnose CAV have been applied to detect disease. This review will examine the current diagnostic and treatment options available to clinicians for CAV.
Recent Findings:
Diagnostic modalities addressing the pathophysiology underlying CAV (arterial wall thickening and decreased coronary blood flow) improve diagnostic sensitivity when compared to traditional (angiography and dobutamine stress echocardiography) techniques.
Summary:
Limited options are available to prevent and treat CAV; however, progress has been made in making an earlier and more accurate diagnosis. Future research is needed to identify the optimal time to modify immunosuppression and investigate novel treatments for CAV.
More Related Videos
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation III: Medical Management
Cardiovascular Drugs: Classification based on Therapeutic Indications